AmSECT : Blogs : Evaluating the Effect on Mortality of a No-Tranexamic acid (TXA) Policy for Cardiovascular Surgery

Tiny Perfusion Letter

AmSECT Staff

Evaluating the Effect on Mortality of a No-Tranexamic acid (TXA) Policy for Cardiovascular Surgery

Click the title to purchase the article.

Objectives: "The authors stopped using tranexamic acid (TXA) in April 2013. The present study aimed to examine the impact of a “no-TXA-use” policy by comparing the adverse effects of TXA and clinical outcomes before and after the policy change in patients undergoing cardiovascular surgery."¹

^{1. Evaluating the Effect on Mortality of a No-Tranexamic acid (TXA) Policy for Cardiovascular Surgery}
^{Maeda T, Ishihara T, Miyata S, Yamashita K, Sasaki H et al.}
^{J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1627-1634}
^Editorial

Released: August 13, 2018 12:10 PM | Updated: August 13, 2018 12:10 PM

Keywords: member news

Recent Stories

Association of Anaesthetists: anaesthesia and peri‐operative care for Jehovah's Witnesses and patients who refuse blood

Updated 2:21AM EST, Fri Dec 14th, 2018

Summary
There are approximately 8.5 million Jehovah's Witnesses and around 150,000 live in Great Britain and Ireland. Based on their beliefs and core values, Jehovah's Witnesses refuse blood comp...

Randomized evaluation of fibrinogen versus placebo in complex cardiovascular surgery: post hoc analysis and interpretation of phase III results (Free)

Updated 2:18AM EST, Fri Dec 14th, 2018

Abstract
graphic
View largeDownload slide
OBJECTIVES
In a multicentre, randomized-controlled, phase III trial in complex cardiovascular surgery (Randomized Evaluation of Fibrinogen...

A Randomized Controlled Trial of Intra-Aortic Adenosine Infusion Before Release of the Aortic Cross-Clamp During Coronary Artery Bypass Surgery

Updated 2:14AM EST, Fri Dec 14th, 2018

Objectives
To assess the feasibility, safety, and potential useful effect of adenosine as a postconditioning agent in patients undergoing coronary artery bypass grafting surgeries.

Des...

AmSECT Membership Eligibility

An Active Member shall be any perfusionist active in the practice of extracorporeal circulation technology. There are also opportunities to become a Transitional Active Member for those less than a year removed from graduation from an approved accredited training program. Other options include; an Associate Membership, International Membership, Perioperative Blood Management Clinician Membership, and Student Membership.

Click Here to Learn More

Looking for Employment Opportunities?

AmSECT members may post an available position for a perfusion specialty at your institution or firm.

Non-members may also post positions free of charge, to be reviewed by National Headquarters prior to posting.

Members - Click to Post a Position
Non-Members - Click to Post a Position

Contact AmSECT

AmSECT National Headquarters
330 N Wabash Ave, Suite 2000
Chicago, IL 60611

Phone: (312) 321-5156
Fax: (312) 673-6656
Email: amsect@amsect.org